VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma

Por Majeti, Bharat K, Lee, Joseph H, Simmons, Brett H, Shojaei, Farbod
Publicado em 2013

The untranslated exon B of human surfactant protein A2 mRNAs is an enhancer for transcription and translation

Por Silveyra, Patricia, Raval, Manmeet, Simmons, Brett, DiAngelo, Susan, Wang, Guirong, Floros, Joanna
Publicado em 2011

Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer

Por Shojaei, Farbod, Scott, Nathan, Kang, Xiaolin, Lappin, Patrick B, Fitzgerald, Amanda A, Karlicek, Shannon, Simmons, Brett H, Wu, Aidong, Lee, Joseph H, Bergqvist, Simon, Kraynov, Eugenia
Publicado em 2012

Contrast Agents for Quantitative MicroCT of Lung Tumors in Mice

Por Lalwani, Kush, Giddabasappa, Anand, Li, Danan, Olson, Peter, Simmons, Brett, Shojaei, Farbod, Arsdale, Todd Van, Christensen, James, Jackson-Fisher, Amy, Wong, Anthony, Lappin, Patrick B, Eswaraka, Jeetendra
Publicado em 2013

Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib

Por Zhang, Cathy C, Yan, Zhengming, Giddabasappa, Anand, Lappin, Patrick B, Painter, Cory L, Zhang, Qin, Li, Gang, Goodman, James, Simmons, Brett, Pascual, Bernadette, Lee, Joseph, Levkoff, Ted, Nichols, Tim, Xie, Zhiyong
Publicado em 2014

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia

Por Kashyap, Manoj K., Amaya-Chanaga, Carlos I., Kumar, Deepak, Simmons, Brett, Huser, Nanni, Gu, Yin, Hallin, Max, Lindquist, Kevin, Yafawi, Rolla, Choi, Michael Y., Amine, Ale-Ali, Rassenti, Laura Z., Zhang, Cathy, Liu, Shu-Hui, Smeal, Tod, Fantin, Valeria R., Kipps, Thomas J., Pernasetti, Flavia, Castro, Januario E.
Publicado no J Hematol Oncol (2017)

Targeting Activin Receptor-Like Kinase 1 (ALK1) Inhibits Angiogenesis and Tumorigenesis Through a Mechanism of Action Complementary to Anti-VEGF Therapies

Por Hu-Lowe, Dana D., Chen, Enhong, Zhang, Lianglin, Watson, Katherine D., Mancuso, Patrizia, Lappin, Patrick, Wickman, Grant, Chen, Jeffrey H., Wang, Jianying, Jiang, Xin, Amundson, Karin, Simon, Ronald, Erbersdobler, Andreas, Bergqvist, Simon, Feng, Zheng, Swanson, Terri A., Simmons, Brett H., Lippincott, John, Casperson, Gerald F., Levin, Wendy J., Stampino, Corrado Gallo, Shalinsky, David R., Ferrara, Katherine W., Fiedler, Walter, Bertolini, Francesco
Publicado em 2011

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies

Por Liu, Shu-Hui, Gu, Yin, Pascual, Bernadette, Yan, Zhengming, Hallin, Max, Zhang, Cathy, Fan, Conglin, Wang, Wenlian, Lam, Justine, Spilker, Mary E., Yafawi, Rolla, Blasi, Eileen, Simmons, Brett, Huser, Nanni, Ho, Wei-Hsien, Lindquist, Kevin, Tran, Thomas-Toan, Kudaravalli, Jyothirmayee, Ma, Jing-Tyan, Jimenez, Gretchen, Barman, Ishita, Brown, Colleen, Chin, Sherman Michael, Costa, Maria J., Shelton, David, Smeal, Tod, Fantin, Valeria R., Pernasetti, Flavia
Publicado no Blood Adv (2017)